The Veterinary Medicine Resource, part of the Laboratory Animal Sciences program, supports The Jackson Laboratory (TJL) Cancer Center investigators by ensuring the health and productivity of their mice. This is accomplished through: 1) a rigorous health and environmental monitoring program; 2) the provision of veterinary care for animals that are injured or suffering from non-infectious disease; and 3) clinical investigations into possible infectious disease problems. In addition, the Veterinary Medicine Resources provides surgically altered mice as requested by Cancer Center investigators. Over the next grant cycle, all Cancer Center mice will be brought to a uniform high health status through a program of rederivation to eliminate several opportunistic microorganisms that are harbored by many TJL research mice. Although not overt pathogens, these microorganisms represent a health threat to immune-deficient mice, and can affect the outcome of research using immunocompetent mice. Rederivation will be performed in conjunction with the Cryopreservation and Rederivation Resource using several approaches, including recovery from cryopreservation, embryo transfer, ovarian transplantation, and hysterectomy derivation. Peggy J. Danneman, V.M.D., M.S., Chief of the Veterinary Medicine Resource and Attending Veterinarian directs all Veterinary Medicine programs and will have primary oversight for the rederivation program. Abigail Smith, Ph.D., Director of Laboratory Animal Sciences, is responsible for overall coordination of the animal health programs. Funds are also requested as partial support for 3 individuals who will be responsible for the day-to-day implementation of the rederivation effort.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA034196-19
Application #
6502391
Study Section
Project Start
1996-08-25
Project End
2006-07-31
Budget Start
Budget End
Support Year
19
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Sharma, Manju; Braun, Robert E (2018) Cyclical expression of GDNF is required for spermatogonial stem cell homeostasis. Development 145:
Shi, Jiayuan; Hua, Li; Harmer, Danielle et al. (2018) Cre Driver Mice Targeting Macrophages. Methods Mol Biol 1784:263-275
Hosur, Vishnu; Farley, Michelle L; Low, Benjamin E et al. (2018) RHBDF2-Regulated Growth Factor Signaling in a Rare Human Disease, Tylosis With Esophageal Cancer: What Can We Learn From Murine Models? Front Genet 9:233
Johnson, Kenneth R; Gagnon, Leona H; Tian, Cong et al. (2018) Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice. Genetics 208:1165-1179
Dominguez, Pilar M; Ghamlouch, Hussein; Rosikiewicz, Wojciech et al. (2018) TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. Cancer Discov 8:1632-1653
Paigen, Kenneth; Petkov, Petko M (2018) PRDM9 and Its Role in Genetic Recombination. Trends Genet 34:291-300
Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol 200:3353-3363
Nakatsuji, Teruaki; Chen, Tiffany H; Butcher, Anna M et al. (2018) A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv 4:eaao4502
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Ye, Fengdan; Jia, Dongya; Lu, Mingyang et al. (2018) Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma. Oncotarget 9:15015-15026

Showing the most recent 10 out of 1156 publications